MRC eyes biomarkers

June 8, 2007

The Medical Research Council has launched £17 million worth of projects designed to explore the indicators of disease known as biomarkers. Colin Blakemore, chief executive of the MRC, said: "We've been using cholesterol and blood pressure as indicators, or biomarkers, of heart disease for years. Now we're going to evaluate promising markers that will speed the development of safer, more effective and better-targeted treatments for a range of diseases including cancer, cardiovascular disease, stroke and Parkinson's disease."

to read this article.

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments